The emergence of high-level resistance to ceftriaxone is giving rise to serious concern about absence of effective treatment options to cure gonococcal infections. Increasing the dosage regimen can be applied to ceftriaxone and azithromycin, but the emergence of high-level resistance has already been reported. Spectinomycin is another active drug but has low efficacy in the treatment of pharyngeal gonorrhoea. Conventional antibiotics could be introduced for gonococcal treatment, but they have some limitations, such as the absence of clinical trials and breakpoint. Combining antibiotics is another promising method to cure patients and to prevent the emergence of resistance. The most important strategy to maintain the efficacy of antibiotics is rapid detection and dissemination control of novel resistant isolate.
|Number of pages||14|
|Journal||Expert Review of Anti-Infective Therapy|
|Publication status||Published - 2016 Feb 1|
Bibliographical notePublisher Copyright:
© 2016 Taylor & Francis.
All Science Journal Classification (ASJC) codes
- Microbiology (medical)
- Infectious Diseases